Stability of nystatin in mouthrinses; effect of pH, temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity.
Vermerie, N., C. Malbrunot, M. Azar, and P. Arnaud. “Stability of Nystatin in Mouthrinses; Effect of Ph Temperature, Concentration and Colloidal Silver Addition, Studied Using an in Vitro Antifungal Activity.” [In eng]. Pharm World Sci 19, no. 4 (Aug 1997): 197-201.
Colloidal silver for lung disease in cystic fibrosis.
Use: Antibacterial, antifungal
Baral, V. R., A. L. Dewar, and G. J. Connett. “Colloidal Silver for Lung Disease in Cystic Fibrosis.” [In eng]. J R Soc Med 101 Suppl 1 (Jul 2008): S51-2.
Surface-enhanced raman analysis of sulfa drugs on colloidal silver dispersion.
Use: General antimocrobial/biocide
Sutherland, W. S., J. J. Laserna, M. J. Angebranndt, and J. D. Winefordner. “Surface-Enhanced Raman Analysis of Sulfa Drugs on Colloidal Silver Dispersion.” [In eng]. Anal Chem 62, no. 7 (Apr 01 1990): 689-93.
Bactericidal activity of colloidal silver against grampositive and gramnegative bacteria.
Afonina, I. A., L. A. Kraeva, and GIa Tseneva. “[Bactericidal Activity of Colloidal Silver against Grampositive and Gramnegative Bacteria].” [In rus]. Antibiot Khimioter 55, no. 9-10 (2010): 11-3.
Studies on interaction of colloidal silver nanoparticles (SNPs) with five different bacterial species.
Khan, S. S., A. Mukherjee, and N. Chandrasekaran. “Studies on Interaction of Colloidal Silver Nanoparticles (Snps) with Five Different Bacterial Species.” [In eng]. Colloids Surf B Biointerfaces 87, no. 1 (Oct 01 2011): 129-38.